Actively Recruiting

Phase 2
Age: 2Days +
All Genders
NCT02532452

Third Party Viral Specific T-cells (VSTs)

Led by Children's Hospital Medical Center, Cincinnati · Updated on 2025-12-16

750

Participants Needed

4

Research Sites

639 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to demonstrate that viral specific T-cells (a type of white blood cell) can be generated from an unrelated donor and given safely to patients with viral infections.

CONDITIONS

Official Title

Third Party Viral Specific T-cells (VSTs)

Who Can Participate

Age: 2Days +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Immunocompromised patient with evidence of viral infection or reactivation
  • Age greater than 1 day
  • For stem cell transplant recipients, at least 21 days have passed since stem cell infusion
  • Clinical status allows tapering of steroids to less than 0.5 mg/kg prednisone or equivalent
  • Must be able to receive CTL infusion in Cincinnati
  • Informed consent obtained by PI or sub-investigator in person or by phone
Not Eligible

You will not qualify if you...

  • Active acute graft-versus-host disease grades II-IV
  • Uncontrolled bacterial or fungal infection
  • Uncontrolled relapse of malignancy requiring chemotherapy
  • Infusion of ATG or alemtuzumab within 2 weeks before VST infusion
  • Biopsy-confirmed acute rejection of solid organ transplant or empiric treatment for suspected acute rejection within the last 30 days

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Akron Children's Hospital

Akron, Ohio, United States, 44308

Actively Recruiting

2

University of Cincinnati Medical Center

Cincinnati, Ohio, United States, 45219

Completed

3

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229

Actively Recruiting

4

The Ohio State University Wexner Medical Center - James Cancer Hospital

Columbus, Ohio, United States, 43210

Actively Recruiting

Loading map...

Research Team

J

Jamie Wilhelm

CONTACT

M

Michael Grimley, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Third Party Viral Specific T-cells (VSTs) | DecenTrialz